Showing 3,481 - 3,500 results of 9,864 for search '"drug"', query time: 0.08s Refine Results
  1. 3481

    Exploring the anticancer potential of Hewittia malabarica through phytochemical analysis and molecular docking study by Shiji Thozhukkad Moosaripparambil, Kannan Vadakkadath Meethal

    Published 2025-02-01
    “…Abstract Natural resources provide valuable medicinal components that are highly sought after as alternatives to synthetic drugs for treating serious diseases like cancer. …”
    Get full text
    Article
  2. 3482

    Investigation of the Proliferation, Apoptosis/Necrosis, and Cell Cycle Phases in Several Human Multiple Myeloma Cell Lines. Comparison of Viscum album QuFrF Extract with Vincristin... by Eva Kovacs

    Published 2010-01-01
    “…Viscum album QuFrF (VAQuFrF) extract is an experimental drug that is not used in the treatment in tumour patients. …”
    Get full text
    Article
  3. 3483

    Structural comparison of human and Plasmodium proteasome β5 subunits: informing selective inhibitor design for anti-malaria agents by Muhammad Yasir, Jinyoung Park, Eun-Taek Han, Won Sun Park, Jin-Hee Han, Wanjoo Chun

    Published 2025-01-01
    “…Abstract Background The Plasmodium proteasome emerges as a promising target for anti-malarial drug development due to its potential activity against multiple life cycle stages. …”
    Get full text
    Article
  4. 3484
  5. 3485

    Ensemble Methods with Voting Protocols Exhibit Superior Performance for Predicting Cancer Clinical Endpoints and Providing More Complete Coverage of Disease-Related Genes by Runyu Jing, Yu Liang, Yi Ran, Shengzhong Feng, Yanjie Wei, Li He

    Published 2018-01-01
    “…The ensemble methodologies provide a more complete coverage of relevant genes, which can facilitate the exploration of cancer mechanisms and the identification of potential drug targets.…”
    Get full text
    Article
  6. 3486

    Hypertension Knowledge, Attitude, and Practice in Adult Hypertensive Patients at a Tertiary Care Hospital in Sri Lanka by Udaya Ralapanawa, Kameera Bopeththa, Noorika Wickramasurendra, Sampath Tennakoon

    Published 2020-01-01
    “…Almost 75% of the patients had optimum drug compliance. It was revealed that forgetfulness was the frequent cause for poor drug compliance.…”
    Get full text
    Article
  7. 3487

    High Performance Liquid Chromatographic Assay for the Simultaneous Determination of Posaconazole and Vincristine in Rat Plasma by Hadeel A. Khalil, Ahmed F. El-Yazbi, Tarek S. Belal, Dalia A. Hamdy

    Published 2015-01-01
    “…The assay was validated as per ICH guidelines and is appropriate for pharmacokinetics drug-drug interaction studies.…”
    Get full text
    Article
  8. 3488

    Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer by Nan Zhang, Xinjia Wang, Yu Li, Yiwei Lu, Chengcheng Sheng, Yumeng Sun, Ningye Ma, Yisheng Jiao

    Published 2025-01-01
    “…Additionally, we explore the role of CPIs in tumor drug resistance to gain a deeper understanding of their potential applications in the development of new anti-cancer therapeutic approaches.…”
    Get full text
    Article
  9. 3489

    MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment by Kouji Banno, Miho Iida, Megumi Yanokura, Iori Kisu, Takashi Iwata, Eiichiro Tominaga, Kyoko Tanaka, Daisuke Aoki

    Published 2014-01-01
    “…Previous approaches to development of siRNA as a drug have provided information for establishment of therapy based on these approaches, and an anti-miR-21 inhibitor has been developed. miRNAs also have effects on drug resistance and may be useful in combination therapy with other drugs.…”
    Get full text
    Article
  10. 3490
  11. 3491

    Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review by Borbón A, Briceño JC, Valderrama-Aguirre A

    Published 2025-01-01
    “…Angélica Borbón,1 Juan Carlos Briceño,2 Augusto Valderrama-Aguirre3 1Technological Innovation Management, University of the Andes, Bogotá, Colombia; 2Department of Biomedical Engineering, Director of Technological Innovation Management Programs, University of the Andes, Bogotá, Colombia; 3Department of Biological Sciences, Faculty of Sciences, Director of the Biomedical Research Institute Group, University of the Andes, Bogotá, ColombiaCorrespondence: Augusto Valderrama-Aguirre, Email a.valderramaa@uniandes.edu.coAbstract: Pharmacogenomics is the integration of genomics and pharmacology to optimize drug response and reduce side effects. In terms of personalized or individualized medicine, PGx is defined as the identification and analysis of specific genetic variants associated with particular drug treatments for each patient. …”
    Get full text
    Article
  12. 3492

    Yield of TB screening in prisons in Tajikistan by S. Moe, M. Asozoda, A. Aung, Z. Dusmatova, F. Akintore, E. Nshimiyimana, A. Zavqibekov, N. Sitali, W.K. Mulanda, T. Cullip, A. Sinha

    Published 2024-08-01
    “…RESULTS: A total of 7,223 screenings were conducted, identifying 31 TB cases, including 17 drug-susceptible TB cases, eight drug-resistant TB cases, and six clinically diagnosed cases. …”
    Get full text
    Article
  13. 3493
  14. 3494

    Validated UPLC-MS/MS Method for Determination of Futibatinib and Its Pharmacokinetics in Beagle Dogs by Heng Li, Hao-Zhe Ding, Yi-Lin Wang, Feng Zhang, Ya-Hao Song, Xiang-Jun Qiu

    Published 2022-01-01
    “…This method would also be used to study drug-drug interaction (DDI).…”
    Get full text
    Article
  15. 3495

    Novel Ethyl 1,5-Disubstituted-1H-Pyrazole-3-Carboxylates as a New Class of Antimicrobial Agents by Radwan Awwad A., Ghorab Mostafa M., Alsaid Mansour S., Alanazi Fares K.

    Published 2014-09-01
    “…Ethyl 5-(4-bromo-2-chlorophenyl)- 1-phenyl-1H-pyrazole-3-carboxylate (16) (MIC = 0.015 μmol mL-1) is more active than fluconazole (0.020 μmol mL-1) as a reference drug against C. parapsilosis.…”
    Get full text
    Article
  16. 3496

    Application of Generative Artificial Intelligence Models for Accurate Prescription Label Identification and Information Retrieval for the Elderly in Northern East of Thailand by Parinya Thetbanthad, Benjaporn Sathanarugsawait, Prasong Praneetpolgrang

    Published 2025-01-01
    “…Both models operated in a zero-shot capacity, utilizing Retrieval-Augmented Generation (RAG) with DrugBank references to ensure contextual relevance and accuracy. …”
    Get full text
    Article
  17. 3497

    Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review by Pedro M Machado, Eduardo José Ferreira Santos, Nicholas Yapp, Pedro Sousa, Bayram Farisogullari, Hermaleigh Townsley

    Published 2025-01-01
    “…Trials of methotrexate (MTX), intravenous immunoglobulin, interferon beta-1a and MTX, MTX and anti-T-lymphocyte immunoglobulin, oxandrolone, MTX and azathioprine, bimagrumab, arimoclomol, and sirolimus provided low-quality to high-quality evidence of having no effect on the progression of IBM.Conclusions Drug interventions for IBM were not effective for most of the outcomes of interest. …”
    Get full text
    Article
  18. 3498

    Targets and Candidate Agents for Type 2 Diabetes Treatment with Computational Bioinformatics Approach by Qiong Wang, Zhigang Zhao, Jing Shang, Wei Xia

    Published 2014-01-01
    “…We sought to explore the molecular mechanism of type 2 diabetes (T2D) and identify potential drug targets and candidate agents for T2D treatment. …”
    Get full text
    Article
  19. 3499

    Plain Language Summary of Publication: What is the effect of the medicine vibegron in the treatment of overactive bladder in patients with and without bladder leakage? by David Staskin, Jeffrey Frankel, Steven G. Gregg, Janet Owens-Grillo

    Published 2025-01-01
    “…The medicine vibegron was approved in 2020 by the US Food and Drug Administration (also called the FDA) to treat overactive bladder. …”
    Get full text
    Article
  20. 3500

    Phenotypic and Molecular Characterization of β-Lactamases among Enterobacterial Uropathogens in Southeastern Nigeria by M. C. Ugwu, M. Shariff, C.M. Nnajide, K Beri, U. M. Okezie, I. R. Iroha, C. O. Esimone

    Published 2020-01-01
    “…The aim of the study was to characterize enterobacterial uropathogens with respect to drug resistance. One hundred (100) enterobacterial uropathogens were studied. …”
    Get full text
    Article